Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS). 

Biotechnology

Passage Bio

William Chou

Rose Johnstone

Rich Mastropietro

Derek Kichula

Sneh Patel

Bin Lu

Patricia Elsasser

Chelsea Difebbo Ortiz

Anne Marie Pierce

Steve Krausert

Glen Kerker II

Sue Browne

Stuart Henderson

Tiffini Voss

Eden Fucci

Kathleen Borthwick

Edgar B. Cale

Samiah Al-Zaidy

Mark Forman

Jiwen Zhang

James M. Wilson

The Scientific Research and Development team at Passage Bio is responsible for spearheading innovative research and development efforts in the field of gene therapy. This team collaborates on designing and conducting experiments, developing AAV-based therapeutics, and optimizing processes to ensure their efficacy for treating rare monogenic CNS disorders. They also focus on biomarker identification and validation to support clinical development, leveraging their expertise to advance the company's therapeutic pipeline.

Scientific Research and Development

Leadership Team

Clinical Operations and Quality Assurance

Scientific Research and Development

About

Team members

Other teams at Passage Bio

Leadership Team

Clinical Operations and Quality Assurance